MBOT Microbot Medical Inc. - Common Stock
NASDAQ · Health Care · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 11, 2026
$1,16
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$1,1452 haftanın en düşüğü
$3,4652 haftanın en yükseği
Piyasa Değeri (MRQ)
$78M
P/E
-4.0
Hisse Başına Kâr
$-0.29
rozetleriniz
52 Haftlık Aralık
$1–$3
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$6
P/E
-4.0
ROE
-24.4%
Net Kâr Marjı
·
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
MBOT Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$1.16
Piyasa Değeri (MRQ)
$78M
P/E
-4.0
Hisse Başına Kâr
$-0.29
ROE
-24.4%
52 Haftlık Aralık
$1–$3
MBOT Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Hisse bölünmeleri
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 05 Eylül 2018 | 1-for-15 | Ters |
| 29 Kasım 2016 | 1-for-9 | Ters |
| 09 Mayıs 2016 | 1-for-12 | Ters |
| 06 Temmuz 2011 | 1-for-10 | Ters |
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Hisse Başına Kâr$-0.292022-12-31 → 2025-12-31
Serbest Nakit Akışı$-13M2016-12-31 → 2025-12-31
Net kar marjı·2018-12-31 → 2018-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | MBOT | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E | -4.05Y ort. ≈-2.9 | ≈-2.9 | · | · | |
| P/S (F/S) | 681.95Y ort. ≈441.7 | ≈441.7 | 12.2 | Aşırı değerli | |
| F/D (MRQ) | 1.15Y ort. ≈3.8 | ≈3.8 | 1.9 | Adil değer | |
| Fiyat / Serbest Nakit Akışı (TTM) | -4.35Y ort. ≈-4.5 | ≈-4.5 | · | · | |
| Fiyat / Nakit Akışı (TTM) | -4.45Y ort. ≈-4.6 | ≈-4.6 | · | · | |
| Price / Tangible Book (Fiyat / Maddi Defter Değeri) | 1.05Y ort. ≈3.8 | ≈3.8 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | MBOT | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| ROA | -30.0%5Y ort. ≈-92.5% | ≈-92.5% | -43.4% | En üst düzey | |
| ROE | -24.4%5Y ort. ≈-158.6% | ≈-158.6% | -41.2% | En üst düzey |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | MBOT | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 18.65Y ort. ≈8.0 | ≈8.0 | 3.8 | Güçlü likidite | |
| Cari Oran (MRQ) | 17.45Y ort. ≈7.7 | ≈7.7 | 3.2 | Güçlü likidite |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Bu oran grubu için henüz veri yok
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Bu oran grubu için henüz veri yok
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
7.8%
Sonraki Rapor
Kas 10, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 10, 2026 | $-0.08 | $-0.08 | -2.3% |
| 31 Mart 2026 | May 12, 2026 | $-0.05 | $-0.08 | 36.1% |
| 31 Aralık 2025 | $-0.04 | $-0.06 | 34.6% | |
| 30 Eylül 2025 | $-0.07 | $-0.06 | -14.4% | |
| 30 Haziran 2025 | $-0.10 | $-0.08 | -22.5% | |
| 31 Mart 2025 | $-0.09 | $-0.13 | 32.1% | |
| 31 Aralık 2024 | $-0.20 | $-0.18 | -8.9% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | · | · | $116.9K | · | |
| R&D Expense | $6M | $7M | $6M | $8M | $6M | $3M | $3M | $3M | $1M | $-901.0K | $-823.0K | $22M | |
| SG&A Expense | $8M | $5M | $4M | $6M | $5M | $6M | $4M | $5M | $4M | $-9M | $-92.0K | $10M | |
| Operating Expenses | · | · | · | $5M | $4M | · | · | · | · | · | $37M | $32M | |
| Operating Income | $-15M | $-12M | $-10M | $-13M | $-11M | $-9M | $-7M | $-7M | $5M | $-10M | $915.0K | $-31M | |
| Interest Expense | · | · | · | · | · | · | · | · | $237.0K | $333.0K | $6.0K | $1M | |
| Interest Income | · | · | · | · | · | · | · | · | · | · | $7.5K | $8.5K | |
| Other Non-op | · | · | · | $-5.0K | · | · | · | · | · | · | $129.8K | $-45.8K | |
| Pretax Income | · | · | · | · | · | · | · | · | · | · | $36M | $33M | |
| Income Tax | · | · | · | · | · | · | $0 | · | · | · | · | · | |
| Net Income | $-13M | $-11M | $-11M | $-13M | $-11M | $-9M | $-7M | $-7M | $-8M | $-10M | $-921.0K | $-33M | |
| EPS (Basic) | $-0.29 | $-0.73 | $-1.05 | $-1.81 | $-1.59 | · | · | · | · | · | · | · | |
| EPS (Diluted) | $-0.29 | $-0.73 | $-1.05 | $-1.81 | · | · | · | · | · | · | · | · | |
| Shares (Basic) | 45,790,362 | 15,644,511 | 10,199,984 | 7,260,344 | 7,108,133 | · | · | · | · | · | · | · | |
| Shares (Diluted) | 45,790,362 | 15,644,511 | 10,199,984 | 7,260,344 | · | · | · | · | · | · | · | · | |
| EBITDA | $-15M | $-12M | $-10M | $-13M | $-11M | · | · | $7M | $-5M | $10M | $-36M | $-30M |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $3M | $2M | $2M | $13M | $20M | $29M | $5M | $11M | $3M | $437.0K | $791.0K | |
| Short-term Investments | $75M | $2M | $4M | $6M | $2M | $5M | $3M | · | · | · | · | · | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | $159.5K | |
| Inventory | $584.0K | · | · | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $644.0K | $300.0K | $152.0K | $532.0K | $300.0K | $521.0K | $286.0K | $568.0K | $81.0K | $191.0K | $25.0K | $1M | |
| Other Current Assets | · | · | $1M | · | $300.0K | $521.0K | $286.0K | $568.0K | $116.0K | $606.0K | · | $64.9K | |
| Current Assets | $80M | $6M | $8M | $9M | $16M | $25M | $36M | $6M | $11M | $3M | $491.0K | $27M | |
| PP&E (Net) | $93.0K | $80.0K | $146.0K | $221.0K | $244.0K | $251.0K | $228.0K | $259.0K | $90.0K | $53.0K | $38.0K | $5M | |
| PP&E (Gross) | $724.0K | $664.0K | $639.0K | $608.0K | $533.0K | $464.0K | $373.0K | $391.0K | $168.0K | $110.0K | $92.0K | $16M | |
| Accum. Depreciation | $631.0K | $584.0K | $493.0K | $387.0K | $289.0K | $213.0K | $145.0K | $132.0K | $78.0K | $57.0K | $54.0K | $10M | |
| Intangibles | · | · | · | · | · | · | · | · | · | · | $45.8K | $356.9K | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | $742.7K | $373.7K | |
| Total Assets | $82M | $6M | $8M | $10M | $17M | $26M | $37M | $6M | $11M | $3M | $529.0K | $32M | |
| Accounts Payable | $511.0K | $165.0K | $357.0K | $116.0K | $279.0K | $275.0K | $284.0K | $630.0K | $78.0K | $512.0K | $25.0K | $2M | |
| Accrued Liabilities | $3M | $2M | $1M | $2M | $1M | $883.0K | $795.0K | $755.0K | $450.0K | $271.0K | $149.0K | $5M | |
| Current Liabilities | $3M | $2M | $4M | $2M | $2M | $1M | $5M | $5M | $528.0K | $783.0K | $174.0K | $11M | |
| Capital Leases | $569.0K | $41.0K | $40.0K | $179.0K | $402.0K | $626.0K | $760.0K | · | · | · | $15.9K | $9.2K | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | $369.4K | $1M | |
| Total Liabilities | $4M | $3M | $4M | $2M | $2M | $2M | $6M | $5M | $556.0K | $1M | $419.0K | $27M | |
| Common Stock | $672.0K | $195.0K | $118.0K | $80.0K | $72.0K | $72.0K | $72.0K | $31.0K | $27.0K | $266.0K | $132.0K | $687.3K | |
| Paid-in Capital | · | · | · | · | · | · | · | $33M | $31M | $14M | $3M | · | |
| Retained Earnings | $-104M | $-91M | $-80M | $-69M | $-56M | $-44M | $-35M | $-28M | $-21M | $-13M | $-3M | $-420M | |
| Treasury Stock | · | · | · | · | · | · | $3M | $3M | · | · | · | · | |
| AOCI | · | · | · | · | · | · | · | · | · | · | $47.4K | $65.4K | |
| Stockholders' Equity | $78M | $4M | $5M | $7M | $14M | $24M | $32M | $1M | $10M | $2M | $-64.0K | $857.0K | |
| Liabilities + Equity | $82M | $6M | $8M | $10M | $17M | $26M | $37M | $6M | $11M | $3M | $529.0K | $32M | |
| Shares Outstanding | 67,158,044 | 19,399,513 | 11,707,317 | 7,890,628 | 7,108,133 | 7,108,133 | 7,185,628 | 3,012,343 | 2,013,193 | 15,848,136 | 13,182,660 | 68,729,774 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $47.0K | $91.0K | $106.0K | $102.0K | $76.0K | $68.0K | $84.0K | $54.0K | · | · | $1M | $1M | |
| Stock-based Comp | $1M | $1M | $1M | $2M | $1M | $2M | $1M | $1M | $479.0K | $676.0K | · | $2M | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | · | $72.0K | $299.0K | |
| Other Non-cash | $-1M | $1M | $707.0K | $-235.0K | $497.0K | · | · | · | · | · | $365.5K | $2M | |
| Operating Cash Flow | $-13M | $-9M | $-9M | $-12M | $-9M | $-7M | $-6M | $-5M | $-5M | $-786.0K | $-765.0K | $-27M | |
| CapEx | $60.0K | $25.0K | $33.0K | $84.0K | $69.0K | $91.0K | $216.0K | $223.0K | $58.0K | $25.0K | $2.0K | $903.9K | |
| Investing Cash Flow | $-72M | $2M | $2M | $-4M | $3M | $-3M | $-2M | $-223.0K | $-58.0K | $-25.0K | $-2.0K | $-425.6K | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | $5M | $5M | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | · | $5M | $5M | |
| Stock Issued | · | · | · | · | · | · | $37M | · | $13M | · | $26M | $19M | |
| Net Stock Activity | · | · | · | · | · | · | · | · | $13M | · | $26M | $19M | |
| Financing Cash Flow | $86M | $8M | $7M | $4M | · | $-3M | $37M | $-18.0K | $13M | $3M | $413.0K | $22M | |
| Net Change in Cash | $810.0K | $646.0K | $-2.0K | $-11M | $-6M | $-13M | $28M | $-6M | $8M | $2M | $-354.0K | $-6M | |
| Free Cash Flow | $-13M | $-9M | $-9M | $-12M | $-9M | · | · | $-6M | $-5M | $-811.0K | $-32M | $-28M |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | 362200.0% | · | · | -31415.3% | · | |
| Net Margin | · | · | · | · | · | · | · | -362000.0% | · | · | -31154.0% | · | |
| Pretax Margin | · | · | · | · | · | · | · | · | · | · | 31154.0% | · | |
| EBITDA Margin | · | · | · | · | · | · | · | 362200.0% | · | · | -30452.3% | · | |
| ROA | -30.0% | -159.4% | -120.2% | -100.1% | -52.6% | · | · | -84.6% | -105.5% | -495.9% | -135.8% | -88.5% | |
| ROE | -24.4% | -311.9% | -181.1% | -205.4% | -70.2% | · | · | -195.9% | -130.2% | -1184.2% | -13931.0% | -314.4% |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 23.3 | 2.4 | 2.1 | 4.3 | 8.0 | · | · | 1.2 | 20.7 | 4.2 | 1.5 | 2.3 | |
| Quick Ratio | 23.0 | 2.2 | 1.7 | 4.0 | 7.8 | · | · | 1.1 | 20.4 | 3.5 | 1.2 | 2.2 | |
| Interest Coverage | · | · | · | · | · | · | · | · | -22.2 | 28.9 | -72.5 | -23.9 |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | 0.0 | · | · | 0.0 | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.15 | $0.18 | $0.38 | $0.92 | $2.02 | · | · | $0.44 | $0.33 | $0.11 | $-0.00 | $0.09 | |
| Cash Flow / Share | $-0.28 | $-0.56 | $-0.84 | · | · | · | · | · | · | · | · | · | |
| Cash / Share | $0.06 | $0.16 | $0.21 | $0.31 | $1.90 | · | · | $1.74 | $0.36 | $0.17 | $0.11 | $0.36 | |
| EPS (TTM) | $-0.29 | $-0.73 | $-1.05 | $-1.81 | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $114.2K | $114.2K | $114.2K | $114.2K | $114.2K | $114.2K | $114.2K | $114.2K | $114.2K | $114.2K | $116.9K | $1M | |
| Net Income TTM | $-13M | $-11M | $-11M | $-13M | $-11M | $-9M | $-7M | $-7M | $-8M | $-10M | $-921.0K | $-33M | |
| Market Cap | $134M | $22M | $19M | $24M | $53M | · | · | $5M | $457M | $1.45B | $75.76B | $104.66B | |
| P/E | -6.9 | -1.5 | -1.6 | -1.7 | · | · | · | · | · | · | · | · | |
| P/S | 1175.8 | 190.2 | 168.1 | 207.9 | 466.7 | · | · | 45.4 | 4001.9 | 12693.8 | 648158.8 | 103420.7 | |
| P/B | 1.7 | 6.2 | 4.3 | 3.3 | 3.7 | · | · | 3.9 | 45.9 | 855.0 | -226687.8 | 17827.6 | |
| P / Tangible Book | 1.7 | 6.2 | 4.3 | 3.3 | 3.7 | 2.0 | · | · | · | · | · | · | |
| P / Cash Flow | -10.3 | -2.5 | -2.3 | -2.1 | -5.7 | · | · | -1.0 | -94.1 | -1844.9 | -2469.5 | -3826.4 | |
| P / FCF | -10.2 | -2.5 | -2.2 | -2.0 | -5.7 | · | · | -0.9 | -93.0 | -1788.0 | -2387.4 | -3704.0 | |
| Earnings Yield | -14.5% | -65.2% | -64.0% | -60.1% | · | · | · | · | · | · | · | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $241.0K | $105.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Cost of Revenue | $884.0K | $103.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Gross Profit | $-643.0K | $2.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| R&D Expense | $2M | $1M | $2M | $1M | $2M | $1M | $2M | $2M | $1M | $1M | $1M | $2M | $1M | $2M | $2M | $2M | |
| SG&A Expense | $4M | $3M | $3M | $3M | $2M | $2M | $1M | $1M | $1M | $1M | $938.0K | $932.0K | $959.0K | $1M | $1M | $2M | |
| Operating Income | $-6M | $-4M | $-4M | $-4M | $-4M | $-3M | $-3M | $-3M | $-3M | $-2M | $-2M | $-3M | $-2M | $-3M | $-3M | $-3M | |
| Other Non-op | · | · | · | · | · | $316.0K | · | · | · | · | · | · | · | · | · | · | |
| Net Income | $-6M | $-4M | $-3M | $-4M | $-4M | $-3M | $-3M | $-3M | $-2M | $-2M | $-3M | $-2M | $-2M | $-3M | $-3M | $-3M | |
| EPS (Basic) | $-0.08 | $-0.05 | $-0.04 | $-0.07 | $-0.10 | $-0.08 | $-0.19 | $-0.20 | $-0.17 | $-0.17 | $-0.23 | $-0.21 | $-0.25 | $-0.36 | $-0.38 | $-0.49 | |
| EPS (Diluted) | $-0.08 | $-0.05 | $-0.04 | $-0.07 | $-0.10 | $-0.08 | $-0.19 | $-0.20 | $-0.17 | $-0.17 | $-0.23 | $-0.21 | $-0.25 | $-0.36 | $-0.38 | $-0.49 | |
| Shares (Basic) | 67,163,613 | 67,158,044 | · | 48,095,384 | 36,488,014 | 31,085,606 | · | 16,471,419 | 14,846,584 | 14,055,973 | · | 11,707,317 | 9,198,806 | 8,013,295 | · | 7,108,133 | |
| Shares (Diluted) | 67,163,613 | 67,158,044 | · | 48,095,384 | 36,488,014 | 31,085,606 | · | 16,471,419 | 14,846,584 | 14,055,973 | · | 11,707,317 | 9,198,806 | 8,013,295 | · | 7,108,133 | |
| EBITDA | $-6M | $-4M | · | $-4M | $-4M | $-3M | · | $-3M | $-3M | $-2M | · | $-3M | $-2M | $-3M | · | $-3M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3M | $4M | $4M | $7M | $4M | $3M | $3M | $479.0K | $2M | $1M | $2M | $1M | $6M | $2M | $2M | $4M | |
| Short-term Investments | $64M | $69M | $75M | $73M | $29M | $27M | $2M | $4M | $4M | $5M | $4M | $7M | $4M | $3M | $6M | $2M | |
| Receivables | $176.0K | $105.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Inventory | $3M | $2M | $584.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $709.0K | $660.0K | $644.0K | $573.0K | $164.0K | $218.0K | $300.0K | $609.0K | $628.0K | $603.0K | $152.0K | $208.0K | $371.0K | $475.0K | $532.0K | $193.0K | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | $1M | · | · | · | · | · | |
| Current Assets | $72M | $77M | $80M | $81M | $33M | $31M | $6M | $5M | $7M | $7M | $8M | $8M | $10M | $6M | $9M | $7M | |
| PP&E (Net) | $316.0K | $188.0K | $93.0K | $78.0K | $75.0K | $78.0K | $80.0K | $99.0K | $122.0K | $132.0K | $146.0K | $184.0K | $180.0K | $196.0K | $221.0K | $258.0K | |
| PP&E (Gross) | · | · | $724.0K | · | · | · | $664.0K | · | · | · | $639.0K | · | · | · | $608.0K | · | |
| Accum. Depreciation | · | · | $631.0K | · | · | · | $584.0K | · | · | · | $493.0K | · | · | · | $387.0K | · | |
| Total Assets | $73M | $78M | $82M | $82M | $33M | $31M | $6M | $5M | $7M | $7M | $8M | $9M | $11M | $6M | $10M | $7M | |
| Accounts Payable | $871.0K | $1M | $511.0K | $509.0K | $503.0K | $186.0K | $165.0K | $246.0K | $178.0K | $96.0K | · | $238.0K | $240.0K | $224.0K | · | $287.0K | |
| Accrued Liabilities | $3M | $2M | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $896.0K | $1M | $1M | $859.0K | $743.0K | $2M | $1M | |
| Current Liabilities | $4M | $3M | $3M | $3M | $3M | $2M | $2M | $1M | $1M | $1M | $4M | $1M | $1M | $1M | $2M | $2M | |
| Capital Leases | $550.0K | $574.0K | $569.0K | $602.0K | $47.0K | $48.0K | $41.0K | $29.0K | $38.0K | $17.0K | $40.0K | $39.0K | $92.0K | $127.0K | $179.0K | $226.0K | |
| Total Liabilities | $4M | $4M | $4M | $4M | $3M | $2M | $3M | $1M | $1M | $1M | $4M | $2M | $1M | $1M | $2M | $2M | |
| Common Stock | $672.0K | $672.0K | $672.0K | $659.0K | $380.0K | $348.0K | $195.0K | $168.0K | $161.0K | $145.0K | $118.0K | $118.0K | $118.0K | $83.0K | $80.0K | $72.0K | |
| Retained Earnings | $-113M | $-108M | $-104M | $-101M | $-97M | $-94M | $-91M | $-88M | $-84M | $-82M | $-80M | $-76M | $-74M | $-72M | $-69M | $-66M | |
| Stockholders' Equity | $69M | $74M | $78M | $78M | $30M | $29M | $4M | $4M | $6M | $6M | $5M | $7M | $9M | $5M | $7M | $6M | |
| Liabilities + Equity | $73M | $78M | $82M | $82M | $33M | $31M | $6M | $5M | $7M | $7M | $8M | $9M | $11M | $6M | $10M | $7M | |
| Shares Outstanding | 67,164,801 | 67,158,044 | 67,158,044 | 65,833,556 | 37,958,316 | 34,744,476 | 19,399,513 | 16,651,433 | 15,965,633 | 14,398,964 | 11,707,317 | 11,707,317 | 11,707,317 | 8,130,628 | 7,890,628 | 7,108,133 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $15.0K | $12.0K | $10.0K | $10.0K | $12.0K | $15.0K | $26.0K | $23.0K | $14.0K | $28.0K | $35.0K | $20.0K | $26.0K | $25.0K | $33.0K | $25.0K | |
| Stock-based Comp | $433.0K | $222.0K | $236.0K | $328.0K | $237.0K | $256.0K | $282.0K | $283.0K | $331.0K | $453.0K | $297.0K | $336.0K | $349.0K | $412.0K | $430.0K | $461.0K | |
| Other Non-cash | · | $-2M | · | · | · | $-544.0K | · | · | · | $-530.0K | · | · | · | $-787.0K | · | · | |
| Operating Cash Flow | $-5M | $-5M | $-4M | $-4M | $-3M | $-3M | $-2M | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-2M | $-3M | |
| CapEx | $142.0K | $108.0K | $25.0K | $13.0K | $9.0K | $13.0K | $7.0K | $0 | $4.0K | $14.0K | $-5.0K | $28.0K | · | · | $1.0K | $5.0K | |
| Investing Cash Flow | $4M | $5M | $-2M | $-45M | $-1M | $-25M | $1M | $140.0K | $1M | $-1M | $3M | $-3M | $-1M | $3M | $-4M | $-5.0K | |
| Financing Cash Flow | · | · | $3M | $51M | $5M | $28M | $3M | $633.0K | $2M | $2M | $0 | $-161.0K | · | · | · | · | |
| Net Change in Cash | $-502.0K | $-56.0K | $-3M | $3M | $870.0K | $102.0K | $3M | $-2M | $1M | $-1M | $1M | $-4M | $4M | $-320.0K | $-2M | $-3M | |
| Free Cash Flow | · | $-5M | · | · | · | $-3M | · | · | · | $-2M | · | · | · | · | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | -266.8% | 1.9% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Margin | -2567.6% | -4114.3% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Net Margin | -2334.9% | -3496.2% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -2567.6% | -4102.9% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| ROA | -10.6% | -6.7% | · | -8.2% | -17.3% | -13.6% | · | -45.6% | -26.9% | -34.9% | · | -30.0% | -21.3% | -28.7% | · | -25.6% | |
| ROE | -11.3% | -7.1% | · | -8.7% | -19.2% | -14.8% | · | -57.6% | -31.8% | -43.0% | · | -38.0% | -25.4% | -34.6% | · | -29.6% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 18.6 | 22.6 | · | 27.5 | 12.1 | 16.2 | · | 3.6 | 5.3 | 5.9 | · | 5.6 | 7.8 | 4.5 | · | 4.0 | |
| Quick Ratio | 17.4 | 21.4 | · | 27.3 | 12.0 | 16.1 | · | 3.2 | 4.8 | 5.4 | · | 5.5 | 7.5 | 4.1 | · | 3.8 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Inventory Turnover | 0.6 | 0.1 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 2.7 | 1.7 | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.03 | $1.10 | · | $1.19 | $0.80 | $0.83 | · | $0.23 | $0.38 | $0.43 | · | $0.63 | $0.81 | $0.60 | · | $0.78 | |
| Revenue / Share | $0.00 | $0.00 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | · | $-0.08 | · | · | · | $-0.09 | · | · | · | $-0.17 | · | · | · | · | · | · | |
| Cash / Share | $0.05 | $0.05 | · | $0.10 | $0.11 | $0.09 | · | $0.03 | $0.15 | $0.08 | · | $0.11 | $0.49 | $0.26 | · | $0.61 | |
| EPS (TTM) | $-0.24 | $-0.26 | · | $-0.44 | $-0.57 | $-0.64 | · | $-0.77 | $-0.78 | $-0.86 | · | $-1.20 | $-1.48 | $-1.72 | · | · |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | $114.2K | $114.2K | $114.2K | · | $114.2K | $114.2K | $114.2K | · | $114.2K | $114.2K | $114.2K | · | $114.2K | |
| Net Income TTM | $-16M | $-14M | · | $-13M | $-13M | $-12M | · | $-11M | $-10M | $-10M | · | $-11M | $-12M | $-13M | · | $-14M | |
| Market Cap | $131M | $162M | · | $201M | $96M | $52M | · | $15M | $16M | $18M | · | $16M | $32M | $17M | · | $34M | |
| P/E | -8.1 | -9.3 | · | -6.9 | -4.4 | -2.4 | · | -1.2 | -1.3 | -1.4 | · | -1.2 | -1.8 | -1.2 | · | · | |
| P/S | · | · | · | 1757.7 | 837.3 | 459.3 | · | 129.7 | 142.6 | 155.0 | · | 142.5 | 278.8 | 148.0 | · | 297.4 | |
| P/B | 1.9 | 2.2 | · | 2.6 | 3.2 | 1.8 | · | 3.9 | 2.7 | 2.9 | · | 2.2 | 3.4 | 3.5 | · | 6.1 | |
| P / Tangible Book | 1.9 | 2.2 | · | 2.6 | 3.2 | 1.8 | · | 3.9 | 2.7 | 2.9 | · | 2.2 | 3.4 | 3.5 | · | 6.1 | |
| P / Cash Flow | · | -32.0 | · | · | · | -18.3 | · | · | · | -7.3 | · | · | · | -5.3 | · | · | |
| Earnings Yield | -12.3% | -10.8% | · | -14.4% | -22.6% | -42.4% | · | -86.5% | -76.5% | -69.9% | · | -86.3% | -54.4% | -82.7% | · | · |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Net Gelir | $-13M | $-11M | $-11M | $-13M | $-11M |
| Seyreltilmiş Hisse Başı Kâr | $-0.29 | $-0.73 | $-1.05 | $-1.81 | · |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Cari Oran | 23.3 | 2.4 | 2.1 | 4.3 | 8.0 |
| Cari Oran | 23.0 | 2.2 | 1.7 | 4.0 | 7.8 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-13M | $-9M | $-9M | $-12M | $-9M |
Kurumsal Sahipler (13F) 83 dosya · $34.4M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
83
Tutulan Değer
$34.4M
Yeni pozisyonlar
11
Çıkan pozisyonlar
17
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 11 (-13 önceki Ç'ye göre) | 17 (+6 önceki Ç'ye göre) | 24 (-3 önceki Ç'ye göre) | 16 (+1 önceki Ç'ye göre) | -2.5M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| VANGUARD GROUP INC | $6.659.442 | 3.329.721 | 19,36% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $5.668.280 | 2.906.810 | 16,48% | Hisse senetleri |
| CIBC Private Wealth Group LLC | $4.434.700 | 1.454.000 | 12,90% | Hisse senetleri |
| Mitsubishi UFJ Asset Management Co., Ltd. | $2.473.483 | 1.268.453 | 7,19% | Hisse senetleri |
| BlackRock, Inc. | $1.759.701 | 902.411 | 5,12% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $1.631.472 | 836.271 | 4,74% | Hisse senetleri |
| UBS Group AG | $1.573.352 | 806.847 | 4,58% | Hisse senetleri |
| DNB Asset Management AS | $1.321.121 | 677.498 | 3,84% | Hisse senetleri |
| STIFEL FINANCIAL CORP | $1.150.367 | 589.924 | 3,35% | Hisse senetleri |
| MARSHALL WACE, LLP | $1.056.831 | 541.963 | 3,07% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.025.363 | 525.827 | 2,98% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $840.514 | 431.033 | 2,44% | Hisse senetleri |
| STATE STREET CORP | $591.960 | 303.569 | 1,72% | Hisse senetleri |
| AlphaCentric Advisors LLC | $487.500 | 250.000 | 1,42% | Hisse senetleri |
| WOLVERINE TRADING, LLC | $335.680 | 104.900 | 0,98% | Alım opsiyonu |
| NORTHERN TRUST CORP | $287.684 | 147.530 | 0,84% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $245.115 | 125.700 | 0,71% | Satım opsiyonu |
| GROUP ONE TRADING LLC | $207.537 | 106.429 | 0,60% | Hisse senetleri |
| JANE STREET GROUP, LLC | $206.961 | 106.134 | 0,60% | Hisse senetleri |
| AMERICAN CENTURY COMPANIES INC | $181.962 | 93.314 | 0,53% | Hisse senetleri |
| CITADEL ADVISORS LLC | $180.375 | 92.500 | 0,52% | Alım opsiyonu |
| MILLENNIUM MANAGEMENT LLC | $168.289 | 86.302 | 0,49% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $166.335 | 85.300 | 0,48% | Alım opsiyonu |
| Cubist Systematic Strategies, LLC | $118.904 | 38.985 | 0,35% | Hisse senetleri |
| Invesco Ltd. | $101.792 | 52.201 | 0,30% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $97.500 | 50.000 | 0,28% | Hisse senetleri |
| Vontobel Holding Ltd. | $93.772 | 48.088 | 0,27% | Hisse senetleri |
| ENVESTNET ASSET MANAGEMENT INC | $92.481 | 47.426 | 0,27% | Hisse senetleri |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $86.385 | 44.300 | 0,25% | Hisse senetleri |
| Cetera Investment Advisers | $85.433 | 43.812 | 0,25% | Hisse senetleri |
| WOLVERINE TRADING, LLC | $75.520 | 23.600 | 0,22% | Satım opsiyonu |
| LAZARI CAPITAL MANAGEMENT, INC. | $71.370 | 36.600 | 0,21% | Hisse senetleri |
| Hilltop Holdings Inc. | $69.740 | 35.764 | 0,20% | Hisse senetleri |
| XTX Topco Ltd | $67.101 | 34.411 | 0,20% | Hisse senetleri |
| SCOTIA CAPITAL INC. | $64.108 | 32.876 | 0,19% | Hisse senetleri |
| Beacon Capital Management, LLC | $62.400 | 32.000 | 0,18% | Hisse senetleri |
| CITADEL ADVISORS LLC | $62.400 | 32.000 | 0,18% | Satım opsiyonu |
| SIMPLEX TRADING, LLC | $58.868 | 30.189 | 0,17% | Hisse senetleri |
| LPL Financial LLC | $57.798 | 29.640 | 0,17% | Hisse senetleri |
| Private Advisor Group, LLC | $44.560 | 22.851 | 0,13% | Hisse senetleri |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $42.107 | 22.279 | 0,12% | Hisse senetleri |
| Squarepoint Ops LLC | $39.558 | 20.286 | 0,12% | Hisse senetleri |
| Vanguard Global Advisers, LLC | $38.943 | 19.971 | 0,11% | Hisse senetleri |
| OSAIC HOLDINGS, INC. | $32.375 | 16.605 | 0,09% | Hisse senetleri |
| Caitong International Asset Management Co., Ltd | $26.411 | 13.544 | 0,08% | Hisse senetleri |
| Qube Research & Technologies Ltd | $26.313 | 13.494 | 0,08% | Hisse senetleri |
| Focus Partners Wealth | $25.321 | 12.985 | 0,07% | Hisse senetleri |
| MORGAN STANLEY | $23.504 | 12.053 | 0,07% | Hisse senetleri |
| Tower Research Capital LLC (TRC) | $22.324 | 11.448 | 0,06% | Hisse senetleri |
| KESTRA PRIVATE WEALTH SERVICES, LLC | $21.450 | 11.000 | 0,06% | Hisse senetleri |
Aktivistler ve %5+ sahipler 6 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Harel Gadot, MEDX Ventures Group LLC ×4 başvurular | 02 Ocak 2020 | · | İlk başvuru | · | SEC |
| Yoseph Bornstein, LSA- Life Science Accelerator Ltd. ×4 başvurular | 26 Ekim 2017 | · | İlk başvuru | · | SEC |
| Moshe Shoham ×4 başvurular | 18 Ekim 2017 | · | İlk başvuru | · | SEC |
| Avram Berkson, Sandra Berkson, Saber Holding GmbH ×3 başvurular | 20 Haziran 2017 | · | İlk başvuru | Pasif yatırım | SEC |
| Technion Research and Development Foundation Ltd. ×2 başvurular | 09 Ocak 2017 | · | İlk başvuru | Pasif yatırım | SEC |
| Alpha Capital Anstalt (2) | 08 Aralık 2016 | · | İlk başvuru | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 36 içeriden öğrenenler · 16 yöneticiler · 20 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Harel Gadot | Chairman, President and CEO | 18 Şubat 2026 A | 136.847 | 0 | 0 | $0 |
| Ian J Massey | Chief Executive Officer | 15 Mart 2016 A | 2.378.460 | 0 | 0 | $0 |
| Martin M Mcglynn | President & CEO | 08 Ocak 2016 F | 2.230.297 | 0 | 0 | $0 |
| Rachel Vaknin | Chief Financial Officer | 18 Şubat 2026 A | · | 0 | 0 | $0 |
| David Ben Naim | Chief Financial Officer | 28 Aralık 2017 A | · | 0 | 0 | $0 |
| Gregory T Schiffman | Chief Financial Officer | 14 Mart 2016 P | 1.599.717 | 0 | 0 | $0 |
| Rodney Kb Young | CFO | 01 Haziran 2013 F | 36.745 | 0 | 0 | $0 |
| Judi R Lum | CFO | 30 Eylül 2005 J | 1.421 | 0 | 0 | $0 |
| Yehezkel Himelfarb | COO and General Manager | 15 Ekim 2017 A | · | 0 | 0 | $0 |
| Juan Diaz-Cartelle | Chief Medical Officer | 18 Şubat 2026 A | · | 0 | 0 | $0 |
| Simon Sharon | General Manager, CTO | 18 Şubat 2026 A | · | 0 | 0 | $0 |
| Eyal Morag | Chief Medical Officer | 01 Ağustos 2023 A | · | 0 | 0 | $0 |
| Kenneth Blair Stratton | General Counsel | 17 Haziran 2016 F | 42.273 | 0 | 0 | $0 |
| Ann Tsukamoto | EVP, Research and Development | 27 Ocak 2015 F | 706.511 | 0 | 0 | $0 |
| Stewart Craig | SVP, Development & Operations | 27 Ocak 2014 F | 405.981 | 0 | 0 | $0 |
| Eliseo Oreste Salinas | EVP and Head of R&D | 06 Haziran 2013 A | 390.000 | 0 | 0 | $0 |
| David James Wilson | Yönetim kurulu üyesi | 01 Nisan 2026 A | · | 0 | 0 | $0 |
| Tal Baruch Wenderow | Yönetim kurulu üyesi | 01 Nisan 2026 A | · | 0 | 0 | $0 |
| Aileen Ptucha Stockburger | Yönetim kurulu üyesi | 01 Nisan 2026 A | · | 0 | 0 | $0 |
| Prattipati Laxminarain | Yönetim kurulu üyesi | 01 Nisan 2026 A | · | 0 | 0 | $0 |
| Martin J. Madden | Yönetim kurulu üyesi | 01 Nisan 2026 A | · | 0 | 0 | $0 |
| Scott R Burell | Yönetim kurulu üyesi | 01 Nisan 2026 A | · | 0 | 0 | $0 |
| Yoseph Bornstein | Yönetim kurulu üyesi | 02 Kasım 2023 A | 246.909 | 0 | 0 | $0 |
| Yoav Zvi Waizer | Yönetim kurulu üyesi | 23 Ekim 2019 A | 0 | 0 | 0 | $0 |
| Moshe Shoham | Yönetim kurulu üyesi | 09 Ekim 2017 S | 1.558.390 | 0 | 0 | $0 |
| Irving Weissman | Yönetim kurulu üyesi | 01 Nisan 2016 A | 558.288 | 0 | 0 | $0 |
| Alan O Trounson | Yönetim kurulu üyesi | 01 Ocak 2016 A | 354.595 | 0 | 0 | $0 |
| John J Schwartz | Yönetim kurulu üyesi | 01 Ocak 2016 A | 334.673 | 0 | 0 | $0 |
| Scott R Greer | Yönetim kurulu üyesi | 01 Ocak 2016 A | 290.183 | 0 | 0 | $0 |
| Eric Bjerkholt | Yönetim kurulu üyesi | 01 Ocak 2016 A | 273.759 | 0 | 0 | $0 |
| Ricardo B Levy | Yönetim kurulu üyesi | 01 Ocak 2016 A | 260.033 | 0 | 0 | $0 |
| Roger M Perlmutter | Yönetim kurulu üyesi | 14 Aralık 2012 A | 13.000 | 0 | 0 | $0 |
| Desmond H Oconnell JR | Yönetim kurulu üyesi | 07 Mart 2007 P | 10.500 | 0 | 0 | $0 |
| Leon Lewkowicz | 10% sahip | 16 Haziran 2017 S | 3.078.214 | 0 | 0 | $0 |
| Alpha Capital Anstalt | 10% sahip | 28 Kasım 2016 J | 1.776.457 | 0 | 0 | $0 |
| George Koshy | · | 24 Mayıs 2016 F | 27.308 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 4 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,42% | 80.526 SH | 02 Ekim 2026 | Günlük |
| IWC · iShares Trust | 0,02% | 229.405 SH | 11 Eylül 2026 | Günlük |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 739.816 SH | 19 Ağustos 2026 | Günlük |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2.109.889 SH | 19 Ağustos 2026 | Günlük |
MBOT Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 9 analist
AL
Medyan hedef
$4.00
+244,8%
2 22,2%
Güçlü Al
6 66,7%
Al
1 11,1%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
3 analist · 2026-10-03Ortalama hedef $6.33 +446,0%
← Tüm hedeflerin altında
Mevcut fiyat $1.16
Düşük$3.00
Ortalama$6.33
Yüksek$12.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| MBOT | $134M | -6.9 | · | · | -24.4% | · |
| LNSR | · | -4.1 | 9.2% | · | · | · |
| LUNG | $92M | -1.7 | 8.0% | -59.7% | -87.7% | 74.2% |
| OM | $67M | -0.7 | 5.1% | -68.3% | -58.0% | 39.1% |
| VANI | $94M | -2.9 | · | · | -257.8% | · |
| STEX | $151M | -0.3 | 122.2% | 29068.8% | -703.0% | · |
| GUTS | $337M | -1.2 | -22.5% | · | 3220.3% | · |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 11, 2026